WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Mar 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-28

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-28	Common Stock	M	2400.0000	$19.3650	Acquired	52113.8749	Direct
2013-02-28	Common Stock	S	2400.0000	$60.4493	Disposed	49713.8749	Direct
2013-02-28	Common Stock	S	2500.0000	$60.5826	Disposed	47213.8749	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-28	Stock Option (Right to Buy)	$19.3650	M	2400.0000	Disposed	2015-05-05	Common Stock (2400.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	446.5318	Indirect
Common Stock	4196.1111	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.43 to $60.54, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commssion, upon request, full information regarding the number of shares sold at each separate price within the ranges set for in footnotes (1) and (2) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at rices ranging from $60.5801 to $60.5839, inclusive.